636 related articles for article (PubMed ID: 2471770)
61. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
Kharkevitch DD; Seito D; Balch GC; Maeda T; Balch CM; Itoh K
Int J Cancer; 1994 Aug; 58(3):317-23. PubMed ID: 7914181
[TBL] [Abstract][Full Text] [Related]
62. Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of action.
Mitchell MS; Harel W; Kan-Mitchell J; LeMay LG; Goedegebuure P; Huang XQ; Hofman F; Groshen S
Ann N Y Acad Sci; 1993 Aug; 690():153-66. PubMed ID: 8368734
[TBL] [Abstract][Full Text] [Related]
63. High proliferative capacity and specific antiautologous melanoma cytotoxicity of a human T-lymphocyte clone derived from tumor-infiltrating lymphocytes.
Gervois N; Heuze F; Diez E; Jotereau F
Hum Immunol; 1990 Jun; 28(2):112-8. PubMed ID: 2141008
[TBL] [Abstract][Full Text] [Related]
64. Differential regulation by interleukin-4 and interferon-gamma of an autologous melanoma-specific cytotoxic T-cell clone and the tumor-infiltrating lymphocytes from which it was established.
Yamada T; Holmes EC; Golub SH
Cancer Commun; 1990; 2(3):113-21. PubMed ID: 2114166
[TBL] [Abstract][Full Text] [Related]
65. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
66. Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells.
Yang TH; Aosai F; Norose K; Ueda M; Yano A
J Immunol; 1995 Jan; 154(1):290-8. PubMed ID: 7995948
[TBL] [Abstract][Full Text] [Related]
67. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity.
Kurane I; Meager A; Ennis FA
J Exp Med; 1989 Sep; 170(3):763-75. PubMed ID: 2475573
[TBL] [Abstract][Full Text] [Related]
68. Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer.
Mukherji B; Guha A; Loomis R; Ergin MT
J Immunol; 1987 Mar; 138(6):1987-91. PubMed ID: 2950174
[TBL] [Abstract][Full Text] [Related]
69. Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy.
Slingluff CL; Darrow TL; Seigler HF
Ann Surg; 1989 Aug; 210(2):194-202. PubMed ID: 2787972
[TBL] [Abstract][Full Text] [Related]
70. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
Int J Cancer; 1990 Nov; 46(5):878-83. PubMed ID: 2146230
[TBL] [Abstract][Full Text] [Related]
71. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
72. Classification of CD4+ T helper cell clones in human melanoma.
Goedegebuure PS; Lee KY; Matory YL; Peoples GE; Yoshino I; Eberlein TJ
Cell Immunol; 1994 Jun; 156(1):170-9. PubMed ID: 7911074
[TBL] [Abstract][Full Text] [Related]
73. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity.
Jahn B; Bergmann L; Weidmann E; Brieger J; Fenchel K; Schwulera U; Hoelzer D; Mitrou PS
Leuk Res; 1995 Feb; 19(2):73-82. PubMed ID: 7869744
[TBL] [Abstract][Full Text] [Related]
74. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
[TBL] [Abstract][Full Text] [Related]
75. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma.
Chakraborty NG; Chattopadhyay S; Mehrotra S; Chhabra A; Mukherji B
Hum Immunol; 2004 Aug; 65(8):794-802. PubMed ID: 15336780
[TBL] [Abstract][Full Text] [Related]
76. Immunoregulation by mouse T-cell clones. I. Suppression and amplification of cytotoxic responses by cloned H-Y-specific cytolytic T lymphocytes.
Simon MM; Moll H; Prester M; Nerz G; Eichmann K
Cell Immunol; 1984 Jun; 86(1):206-21. PubMed ID: 6202426
[TBL] [Abstract][Full Text] [Related]
77. Western blot analysis of antigens on melanoma cells recognized by cytotoxic T cells.
Hersey P; MacDonald M; Werkman H
J Natl Cancer Inst; 1988 Aug; 80(11):826-35. PubMed ID: 3260628
[TBL] [Abstract][Full Text] [Related]
78. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
[TBL] [Abstract][Full Text] [Related]
79. Role of uncultured human melanoma cells in the proliferation of autologous tumor-specific cytotoxic T lymphocytes.
Salmeron MA; Balch CM; Ross MI; Itoh K
Cell Immunol; 1992 Aug; 143(1):228-37. PubMed ID: 1623565
[TBL] [Abstract][Full Text] [Related]
80. Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15.
Takahashi T; Chapman PB; Yang SY; Hara I; Vijayasaradhi S; Houghton AN
J Immunol; 1995 Jan; 154(2):772-9. PubMed ID: 7814883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]